Continuous glucose monitoring market

Continuous glucose monitoring market is predicted to expand at a 13.60% CAGR during the
period from 2013 to 2019.
Transparency Market Research has published a new report on the global continuous glucose
monitoring market. According to the report, the global continuous glucose monitoring market was
valued at US$370 mn in 2012 and is predicted to reach US$910 mn by 2019. The report, titled
‘Continuous Glucose Monitoring Market - Global Industry Analysis, Size, Share, Growth, Trends
and Forecast, 2013 - 2019’, states that the global continuous glucose monitoring market is predicted
to expand at a 13.60% CAGR during the period from 2013 to 2019.
The demand for continuous glucose monitoring systems (CGMS) has increased rapidly as these
systems display real-time glucose levels from the patient’s body at regular intervals. CGMS use
wireless technology to measure glucose levels. As per the International Diabetes Federation (IDF),
globally, about 382 mn people were identified with diabetes in 2013 and the number is predicted to
reach 592 mn by 2035. The increasing number of people being diagnosed with diabetes is expected
to propel the global continuous glucose monitoring market throughout the forecast period.
Read Report overview @ https://www.transparencymarketresearch.com/continuous-glucosemonitoring.html
The global continuous glucose monitoring market is segmented on the basis of geography and
device/brand. By device/brand, the global continuous glucose monitoring market is classified into
guardian real time CGM system, freestyle navigator, dexcom seven plus CGM system, dexcom G4
platinum, minimed paradigm revel/veo system, and others. Based on device/brand, the global
continuous glucose monitoring market is analyzed by factors such as sales revenue, commercial
launch, usage, geographical presence, and technical developments. In terms of market share, in
2012, the guardian real time CGM system dominated the global continuous glucose monitoring
market, followed by dexcom seven plus CGM systems. Demand for the dexcom G4 platinum CGM
system also is predicted to expand rapidly during the forecast period.
The global continuous glucose monitoring market is widespread, as leading companies offer
innovative CGMS in different regions. Some of the leading companies in the global continuous
glucose monitoring market are Medtronic, Inc., Abbott Diabetes Care, Inc., Nova Biomedical
Corporation, GlySens, Inc., Insulet Corporation, Dexcom, Inc., Bayer AG, and Senseonics, Inc.
Request Sample [email protected] https://www.transparencymarketresearch.com/sample/sample.php?
flag=S&rep_id=1169
By geography, the global continuous glucose monitoring market is classified into North America,
Europe, Asia Pacific, and Rest of the World. In 2012, North America led the global continuous
glucose monitoring market. The North America continuous glucose monitoring market is driven by
factors such as the rising obese population, increasing technical advancements in medical
equipment, and increasing aging population. The Asia Pacific continuous glucose monitoring
market is predicted to grow rapidly during the forecast period. Changing lifestyles, economic
development, and increasing patient awareness are the driving factors for the Asia Pacific regional
market.
Factors such as calibration issues and unfavorable reimbursement policies are predicted to hamper
the growth of the global continuous glucose monitoring market. Increase in demand for point of
care testing (POCT) is expected to create growth opportunities for the global continuous glucose
monitoring market in the coming few years.